- •Acknowledgment
- •Abbreviations and Glossary
- •Contents
- •Introduction
- •1: Should You Become a VR Surgeon?
- •2.2 A Word of Caution
- •Introduction
- •3: Fundamental Rules for the VR Surgeon
- •3.4 The “What, When, How – and Why” Questions
- •3.5 Don’t Start What You Cannot Finish
- •3.6 Common Sense vs Dogma
- •3.7 Maximal Concentration During the Entire Operation
- •3.8 Make Life as Easy for Yourself as Possible
- •3.9 Under Peer Pressure: To Yield or Not to Yield
- •3.10 Referral of the Patient
- •3.11 The Rest of the Eyeball…
- •4.1 What If the Surgeon Has Tremor?
- •4.2 How Important Is Good Dexterity?
- •4.5 Combined Surgery or Cataract Surgery Separately?
- •4.7 How Much Confidence in Himself Should the VR Surgeon Have?
- •4.8 How Long Do Vitrectomies Take?
- •4.9 Was Surgery Successful?
- •5.1 The “Target” of Counseling
- •5.2 The Patient Does Not Know Most of What Is so Obvious to the Surgeon
- •5.3 Communicating with the Patient
- •5.4 Coaching vs Trying to Be Objective
- •5.5 The Ultimate Treatment Decision: “Whose Eye Is It?”
- •5.6 Which of the Two Eyes to Operate on First?
- •5.7 What if the Eye Has Two Diseases?
- •5.8 What if the Eye Has Severe Visual Loss and the Chance of Improvement with Another Surgery Is Low?
- •5.9 Empathy: The Single Most Important Component of Counseling
- •5.10 The Prognosis with the Chosen Surgical Option
- •5.11 If the Patient Chooses to Undergo Surgery
- •5.12 The Benefits of Proper Counseling
- •5.14 The Dogmas
- •6: The VR Surgeon’s Relation to His Nurse
- •7: Examination
- •8: The Indication Whether to Operate
- •8.1 The Argument in Favor of Surgery
- •8.3 The Age of the Patient
- •8.4 The Condition of the Fellow Eye
- •11: The Surgeon’s Relation to Himself
- •11.3 Self-Examination
- •Introduction
- •12.1.1 The Pump
- •12.1.1.1 Peristaltic Pump: Flow Control
- •12.1.2 The Probe
- •12.1.2.2 Port Location
- •12.1.2.3 Port Configuration and Size
- •12.1.2.4 Cut Rate
- •12.1.2.6 Probe Length
- •12.1.3 The Light Source/Pipe
- •12.1.4 The Infusion Supply
- •12.1.5 The Trocar
- •12.1.6 The Cannula
- •12.1.7 System to Inject/Extract Viscous Fluid
- •12.1.8 The Pedal
- •12.1.10 Endodiathermy Probe
- •12.1.11 The User Interface of the Vitrectomy Console
- •12.1.12 Troubleshooting
- •12.2 The Microscope
- •13: Instruments, Tools, and Their Use
- •13.2.1.1 General Concepts of Working with Squeezable Instruments
- •13.2.1.2 The Handle
- •13.2.1.3 Forceps
- •13.2.1.4 Scissors
- •13.2.2 Hybrid Instruments
- •13.2.2.2 Retractable Instruments
- •13.2.3 Non-squeezable Hand Instruments
- •13.2.3.1 Bent (Hooked, Barbed) Needle
- •13.2.3.2 Membrane Scraper
- •13.2.3.3 Spatula/Pic
- •13.2.3.4 Intraocular Magnet
- •13.3.1 Membrane Dissection (“Viscosurgery”): Viscoelastics as a Spatula
- •13.3.2 Opening a Closed Funnel
- •14: Materials and Their Use
- •14.2 Intravitreal Gas
- •14.3 Silicone Oil
- •14.3.1 Types of Silicone Oil
- •14.3.3 Complications Related to Silicone Oil Use
- •14.3.4 Complications Related to Silicone Oil Use Removal
- •14.4 PFCL
- •14.6 Sutures
- •15: Anesthesia
- •15.1 How to Decide the Type of Anesthesia
- •15.2 If Local Anesthesia Is Chosen
- •15.3 Medications If Local Anesthesia Is Used
- •16: The Surgeon at the Operating Table
- •16.1 The OR Personnel
- •16.2 The Operating Table and the Surgeon’s Chair
- •16.2.1 The Operating Table
- •16.2.2 The Surgeon’s Chair
- •16.4 The Microscope
- •16.5 The BIOM
- •16.5.1 BIOM: The Advantages
- •16.5.2 BIOM Use: Practical Information
- •16.5.3 BIOM: Setting Up for Daily Use
- •16.5.4 BIOM: Checklist
- •16.5.5 BIOM: Troubleshooting
- •16.6 The Patient
- •16.7 The Surgeon
- •16.7.2 At the Start of Vitrectomy
- •16.7.3 Staring into the Microscope
- •16.8 Music in the OR
- •16.9 The Brightness in the OR
- •16.10 The Quality of the Air in the OR
- •16.12 The Blueprint of the OR
- •16.13 The Captain in the OR
- •16.14 The Fundamental Technical Rules of Performing Intravitreal Surgery
- •Introduction
- •17.3 The Endoscope Approach (EAV)
- •17.4 Portable Systems
- •17.5 3D Viewing
- •18.1 Disinfection and Draping
- •18.2 The Monocular Patient
- •18.3 At the Conclusion of the Operation
- •19: The Speculum and Its Placement
- •19.1 General Considerations
- •19.2 Speculum Placement
- •20.3 Injecting into the Vitreous Cavity During Surgery
- •21: Sclerotomies and the Cannulas
- •21.2 Location of the Sclerotomies
- •21.2.1 Distance from the Limbus
- •21.2.2 Location in Clock Hours
- •21.2.3 In Case of a Reoperation
- •21.2.4 In Case of Scleral Thinning
- •21.3 Inserting the Cannula
- •21.4 The Order of Cannula Placement
- •21.5 If the Palpebral Opening Is Small
- •21.6 Checking the (Infusion) Cannula
- •21.6.1 Cannula Under the Choroid/Retina: Prevention
- •21.6.2 Cannula Under the Choroid/Retina: Management
- •21.6.3 Infusion Going Under the Choroid/Retina: Management
- •21.7 The Cannulas in Use
- •21.8 The Removal of the Cannulas
- •21.8.1 Hypotony: The Causes
- •21.8.2 Hypotony: The Consequences
- •21.8.3 Hypotony: Prevention
- •21.8.4 Hypotony: Postoperative Management
- •22: Illumination
- •22.1 The Light Pipe
- •22.3 Light Built into the Handheld Instruments
- •24: Using the Vitrectomy Probe
- •24.1 Removal of the Vitreous
- •24.2 Removal of Proliferative Membranes
- •24.3 Removal of the Retina
- •24.4 Removal of the Lens
- •25: Maintaining Good Visualization
- •25.1.1 The Microscope
- •25.1.2 The Contact Lens
- •25.1.3 The Corneal Surface
- •25.1.4 The Corneal Stroma
- •25.2 Internal Factors
- •25.2.2 Pupil
- •25.2.2.1 Mechanical Forces Preventing Pupil Dilation
- •25.2.2.2 Intracameral Adrenalin or Visco
- •25.2.2.4 Iris Ring
- •25.2.2.5 Iridotomy
- •25.2.3 Lens
- •25.2.3.1 Cataract
- •25.2.3.2 “Feathering”
- •25.2.3.3 “Gas Cataract”
- •25.2.3.4 “Lens Touch”
- •25.2.4.1 Phimosis of the Anterior Capsule
- •25.2.4.2 Deposit on the Anterior IOL Surface
- •25.2.4.3 Problems with the IOL Itself
- •25.2.4.4 Fluid Condensation
- •25.2.5 The Posterior Capsule
- •25.2.6 The Vitreous Cavity
- •25.2.7 Epiretinal (Subhyaloidal) Materials
- •25.2.7.1 Blood
- •25.2.8 The Surgeon’s Actions
- •25.2.9 “Chromovitrectomy”
- •26.1.1 Vitreous Macroanatomy
- •26.1.2 Vitreous Biochemistry and Its Anatomical and Functional Implications
- •26.1.3 Retinal Histology and Macroanatomy
- •26.1.4 Anterior Segment Dimensions
- •26.2 External Anatomy for the VR Surgeon
- •26.3 Physiology: What Keeps the Retina Attached?
- •26.3.1 The RPE Pump
- •26.3.3 Presence of the Vitreous Gel
- •27: The Basics of Vitreous Removal
- •27.1 The Rationale for PPV
- •27.2 How Much Vitreous to Remove?
- •27.3 Recognizing the Presence of the Vitreous Gel
- •27.3.1 Mechanical Aids
- •27.3.2 Air (Pneumovitrectomy)
- •27.3.3 Stains and Markers
- •27.4 The Sequence of Vitreous Removal
- •27.5.2 Vitrectomy Anterior to the Equator
- •27.5.3 Vitrectomy Behind the Lens
- •28: Scleral Indentation
- •28.1 The Advantages of Scleral Indentation
- •28.2 The Mechanics of Vitrectomy with Scleral Indentation
- •28.3 Internal vs External Illumination
- •28.5 External Illumination and Nurse Indentation
- •28.6 Instrumentation and Technique
- •29: Cryopexy
- •29.1 Indication in RD
- •29.2 Surgical Technique
- •29.3 Cryopexy as a Destructive Force
- •30: Endolaser
- •30.1 The Consequences of Laser Treatment
- •30.2 The Setup
- •30.3 The Technique of Endolaser Treatment
- •30.3.1 General Considerations
- •30.3.2 Panretinal Treatment
- •30.3.3 Endolaser Cerclage and Its Complications
- •30.3.4 Endolaser as a Walling-Off (Barricading) Tool
- •30.3.5 Endolaser as a Welding Tool
- •30.4 Peripheral Laser and the Beginner VR Surgeon
- •30.5 Endocyclophotocoagulation
- •30.6 Laser Cerclage at the Slit Lamp
- •31: Working With and Under Air
- •31.1.1 Attached Retina
- •31.3 The Utilization of an Air Bubble
- •32: Working with Membranes
- •32.1.1 Instrumentation and Infrastructure
- •32.1.2 Opening the ILM
- •32.1.2.1 Sharp Opening: Incision First
- •32.1.2.2 Blunt Opening: No Incision
- •The Scraper
- •32.1.3 Peeling the Membrane
- •32.1.4 The Extent of ILM Peeling
- •32.1.5 What If the ILM Cannot Be Peeled?
- •32.1.6 ILM Removal in Eyes with Detached Macula
- •32.1.6.1 Reattaching the Macula First
- •32.1.6.2 Peeling When the Macula Is Still Detached
- •32.2.2 Removal Technique
- •32.2.2.1 Staining or Not?
- •32.2.2.2 Instrumentation
- •32.2.2.3 Location of the Point of Attack
- •32.2.2.4 The Major Risks When First Grabbing an EMP
- •32.2.2.5 The Direction of Peeling: Centripetal vs Centrifugal
- •32.2.2.6 The Speed of Peeling
- •32.2.2.7 The Extent of Peeling
- •32.2.2.8 ILM Peeling
- •32.2.2.9 Completion of Surgery
- •32.3.1.1 Recognition
- •32.3.1.2 The Goals of Surgery
- •32.3.1.3 Instrumentation
- •32.3.1.4 Surgical Steps
- •32.3.1.5 Closed Funnel/Retinal Incarceration
- •32.3.1.6 ILM Removal
- •32.4 Subretinal Membranes/Strands
- •33.1 Retinectomy
- •34: Chromovitrectomy
- •34.1 Posterior Vitreous Cortex
- •34.3.1 False-Positive Staining with ICG
- •34.3.2 Injection Technique for Staining the ILM
- •34.4 Newly Formed (PVR) Membranes
- •35: Tamponades
- •35.2 Gases
- •35.2.1 General Considerations
- •35.2.3 Gas Injection into the Nonvitrectomized Eye
- •35.2.4 The Eye with Gaseous Tamponade
- •35.3.1 Indications to Use Heavier-Than-Water Liquids
- •35.3.2 Surgical Technique
- •35.3.2.1 Implantation
- •35.4 Silicone Oil
- •35.4.1 Selecting the Type of Silicone Oil to Implant
- •35.4.2 General Considerations
- •35.4.3 Indications
- •35.4.3.1 Semipermanent Tamponade
- •35.4.3.2 Permanent Tamponade
- •35.4.4 Implantation
- •35.4.5 With Silicone Oil in the Eye
- •35.4.5.1 General Considerations
- •35.4.5.2 Emulsification
- •35.4.6 Removal
- •35.4.6.1 Timing
- •35.4.6.2 Surgical Technique
- •35.5 Exchanges
- •35.6 If the Eye Is Aphakic
- •36: Submacular Hemorrhage
- •36.1 The Nonsurgical Approach: Intravitreal Gas and tPA
- •36.2 Removal of the Clot In Toto
- •36.4 The Minimalistic Surgical Approach
- •37: Subretinal Biopsy
- •38: Combined Surgery
- •38.1 Phacoemulsification
- •38.2 Lensectomy
- •38.2.1 Lens In Situ
- •38.3.1 Lens In Situ
- •38.3.2 Lens in Vitreous
- •38.4.2 No IOL Implantation
- •38.5 Capsule Removal
- •38.5.1 Indications
- •38.5.2 Surgical Technique
- •38.6.1 Advantages
- •38.6.2 Surgical Technique
- •38.6.3 Subsequent Sub/luxation of an Iris-Claw IOL
- •38.6.3.1 Subluxated Lens
- •38.6.3.2 Luxated Lens
- •39: AC Basics
- •39.1 Paracentesis
- •39.2 Iris Prolapse
- •39.3 Anterior Synechia
- •39.5 Material in the AC
- •40.2 Retinal Tear
- •40.3 Reopening of a Posterior Scleral Wound
- •40.4 Lens/IOL Trauma
- •41: Pediatric Patients
- •42: The Highly Myopic Eye
- •42.1 The Risk of RD If Cataract Surgery Is Needed
- •42.2 Vitrectomy in the Highly Myopic Eye
- •42.3 Posterior RD over a Staphyloma
- •43: Intravitreal Injections
- •Introduction
- •44: Dropped Nucleus and Dislocated IOL
- •44.1 General Considerations
- •44.1.2 Dislocated IOL
- •44.2 Surgical Technique
- •44.2.1 Dropped Nucleus
- •45: Endophthalmitis
- •45.1 General Considerations
- •45.1.1 Etiology
- •45.1.2 Clinical Diagnosis
- •45.1.3 Timing
- •45.1.4 Treatment Options and Management Philosophy
- •45.2 Surgical Technique
- •45.3 Posttraumatic Endophthalmitis
- •46: Floaters
- •46.1 General Considerations
- •46.1.1 Indication for Surgery
- •46.1.2 Timing of Surgery
- •46.2 Surgical Technique
- •47: Hyphema
- •47.1 General Considerations
- •47.1.1 The Rationale for Surgical Removal
- •47.1.2 Medical Treatment
- •47.2 Surgical Technique
- •47.2.1 Liquid Blood
- •47.2.1.1 Monomanual Technique
- •47.2.1.2 Bimanual Technique
- •47.2.2 Clotted Blood
- •48: Iris Abnormalities
- •48.1 General Considerations
- •48.1.2 Timing of Iris Reconstruction
- •48.2 Surgical Technique
- •48.2.2 Iridodialysis
- •48.2.3 Permanent Mydriasis
- •49: Macular Disorders: Edema
- •49.1 General Considerations
- •49.1.1 Etiology
- •49.1.2 Indications for Treatment: Surgical or Nonsurgical?
- •50.1 General Considerations
- •50.1.1 VMTS
- •50.1.2 Cellophane Maculopathy
- •50.1.3 Macular Pucker
- •50.1.4 Macular Hole
- •50.2.1 VMTS
- •50.2.2 Cellophane Maculopathy
- •50.2.3 Macular Pucker
- •50.2.4 Macular Hole
- •50.2.5 If Surgery Failed for a Macular Hole
- •51: Optic Pit
- •51.1 General Considerations
- •51.2 Surgical Technique
- •52.1 General Considerations
- •52.1.1 Indications
- •52.1.2 Preoperative Considerations
- •52.2 Surgical Technique
- •53.1 General Considerations
- •53.2 Surgical Technique
- •54: Retinal Detachment
- •54.1.1 RD Due to a Horseshoe or Giant Tear
- •54.1.2 RD Due to a Dialysis
- •54.1.3 RD Due to a Round Hole
- •54.1.4 RD Due to a Staphyloma
- •54.2 Additional Information About RD
- •54.2.1 History
- •54.2.3 Clinical Course
- •54.2.4 Using Laser to Prevent RD Development
- •54.2.4.1 Prophylaxis in the Affected Eye (RD, Current or Past)
- •54.2.4.2 Prophylaxis in the Fellow Eye
- •54.2.4.3 The Patient with a History of a Retinal Tear (No RD)
- •54.3 Treatment Principles
- •54.3.2 The Goals of Surgery
- •54.3.3 Prognosis
- •54.4.1 Preoperatively
- •54.4.2.1 Initial Steps
- •54.4.2.2 Creating a Chorioretinal Adhesion
- •54.4.2.3 Drainage of the Subretinal Fluid
- •54.4.2.5 Suturing
- •54.4.2.7 Adjusting the Buckle
- •54.4.2.8 Closing the Conjunctiva
- •54.4.2.9 Gas Tamponade
- •54.4.3 Major Intraoperative Complications of SB
- •54.5 Vitrectomy
- •54.5.2.3 Intraoperative Retinal Reattachment
- •54.5.2.4 Laser Retinopexy
- •54.5.2.5 Intraocular Tamponade
- •54.5.2.6 Postoperative Positioning
- •54.5.3 Follow-Up Visits
- •54.5.4 Prognosis
- •54.5.5 RD After Silicone Oil Removal
- •54.6 Pneumatic Retinopexy
- •54.6.1 General Considerations
- •54.6.2 Patient Selection
- •54.6.3 Surgical Options
- •54.6.3.1 Cryopexy, Followed by Gas Injection
- •54.6.3.2 Gas Injection, Followed by Laser
- •54.7 Reoperation
- •55: RD, Tractional and Combined
- •55.1.1 Characteristics of the RD
- •55.1.2 Management Principles
- •56: RD, Central
- •56.1 General Considerations
- •56.2 Surgical Technique
- •57: Retinoschisis
- •57.1.1 Anatomy and Pathophysiology
- •57.1.2 Prophylactic Laser Treatment
- •57.2 Surgical Technique
- •58.1 General Considerations
- •58.1.1 Treatment Options
- •58.1.2 The Vitrectomy Option
- •58.2 Surgical Technique
- •59: Scleroplasty
- •59.1 General Considerations
- •59.2 Surgical Technique
- •60: Suprachoroidal Hemorrhage
- •60.1.1 Indications for Surgery
- •60.1.2 Timing of Surgery
- •60.2 Surgical Technique
- •61: Uveitis, Posterior
- •62: Vitreous Hemorrhage
- •62.1 General Considerations
- •62.2 Surgical Technique
- •62.3 Severe Bleeding in a Young Patient
- •62.4 Rebleeding in a Vitrectomized Eye
- •63: Trauma
- •63.1 The Timing of Surgery
- •63.2 Contusion
- •63.3 Wound Toilette
- •63.5 Suturing the Sclera
- •63.6 Subluxated Lens
- •63.7 IOFB
- •63.7.2 Posterior Segment
- •63.8 Perforating Trauma and Ruptures
- •63.9 NLP and Sympathetic Ophthalmia
- •63.11 Hemorrhagic RD
- •63.12 Additional Considerations
- •64: Postoperative Care
- •Further Reading
- •Appendix
- •Part 2. Important Personal Experiences
460 |
54 Retinal Detachment |
|
|
not decrease the RD risk; second, he is supposed to undergo a detailed fundus examination every few months for the rest of his life.
Table 54.4 RD prophylaxis in persons with a retinal break in one eye and various conditions in the fellow eye*
Variablea |
Fellow eye |
Commentb |
Round hole, asymptomaticc |
No pathology/history |
No treatment |
|
RD |
Laser cerclage, focal laser, |
|
|
observation |
Round hole, symptomatic |
No pathology/history |
Laser cerclage, focal laser, |
|
|
observation |
|
RD |
Laser cerclage |
Dialysis |
No pathology/history |
Laser walling-off |
Flap (horseshoe) tear, |
No pathology/history |
Focal laser, observation |
asymptomatic |
RD |
Laser cerclage |
Flap (horseshoe) tear, |
No pathology/history |
Laser cerclage, focal laser, |
symptomatic |
|
observation |
|
RD |
Laser cerclage |
Giant tear |
No pathology/RD |
Laser cerclaged |
*No or only clinical RD is present in the eye with the break in question.
aTo keep it simple, additional risk factors (high myopia, pseudophakia, hereditary vitreoretinal degenerations etc.) are not listed there; however, these should also be taken into account when the ophthalmologist considers treatment vs observation.
bIf more than one option is listed, my personal preference is the option listed Þrst; the rest are in decreasing order. The actual decision rests with the patient.
cThe ophthalmologist should always be cautious when interpreting Òasymptomatic.Ó Quite a few patients have symptoms but do not recognize them until speciÞcally asked (Òhave you seen ßashes of light when you were in a dark environment and you moved your gaze/eye around?Ó).
dOr PPV; it is unlikely that RD is not present.
Q&A
Q Why laser cerclage and not focal laser?
AClinical experience shows that the RD often originates in areas that had appeared normal in prior examinations. Focal treatment does not offer extra protection when compared to observation.
54.3Treatment Principles
54.3.1 The Timing of Surgery26
In principle, as soon as possible, but certain other factors must also be incorporated into the decision-making process.
26 See also above, Sect. 54.2.3 and Table 9.1.
54.3 Treatment Principles |
461 |
|
|
Q&A
Q What if the patient with an RD arrives Friday afternoon?
AWith rare exceptions (see below), surgery can safely be postponed until Monday morning, when all is available to give it the best chance of success. The patient has to understand the risks if he is unwilling to remain in bed until the operation (counseling, see Chap. 5).
¥Patching both eyes is highly inconvenient for the patient, but it eliminates eye/ head movement and thus greatly reduces the height of the detachment Ð less crucial if PPV is performed, but very helpful in bullous RDs if the surgeon plans to do SB.
¥If the macula is on, the patient should be positioned so that the ßuid does not get in the macula.
¥The rods recover rather well,27 even if the RD is long standing.
¥The cones do not recover that well, but even if the macula is off for a few days, the chance of recovering reading vision is still 70%.
¥The most urgent situation is an RD that is just about to reach into the fovea.
54.3.2 The Goals of Surgery
The surgeonÕs goals with surgery, irrespective of its type, are the following:
¥Address the traction.28
¥Bring the neuroretina in apposition with the RPE.
¥Prevent ßuid re-entry into the subretinal space through the break.29
The surgeon can choose between 3 different treatment options.30 Of these SB and pneumatic retinopexy are mostly exterior31 procedures; PPV is solely internal. Table 54.5 presents a comparison between SB and PPV, which are occasionally used in combination.
27That is, the visual Þeld.
28As mentioned above, it is extremely rare for VR traction not to be the underlying cause of the RD. Consequently, this must be the primary target of the surgery (whichever of the 3 options is chosen), with the break being a close second.
29Akin to closing and locking the door and thus preventing access to a room.
30There is a fourth option, a temporary buckle (balloon), but it is out of favor today.
31Except that a gas tamponade is always used in pneumatic retinopexy and often in SB. In the latter, drainage also makes it an intraocular procedure.
462 |
|
54 Retinal Detachment |
|
|
|
Table 54.5 Comparison of SB versus PPV for RD* |
|
|
Variable |
SB |
PPV |
Surgery rational? |
No: an internal problem is |
Yes: an internal problem is |
|
addressed by an external |
addressed by an internal |
|
procedure. The eyewall is |
procedure. The detached |
|
pushed toward the |
retina is pushed toward its |
|
detached retina, causing a |
normal resting place, |
|
permanent deformation in |
maintaining the original |
|
the contour of the eyewall |
contour of the eyewall |
Main purpose of surgery |
Weakening of the traction |
Elimination of the traction force |
|
force to the point that the |
|
|
traction becomes |
|
|
ineffective |
|
Able to address |
No, or with signiÞcant |
Yes |
nonrhegmatogenous RD? |
morbidity (posterior break |
|
|
or staphyloma-spanning |
|
|
RD in high myopes) |
|
Can be employed if severe |
No |
Yes |
PVR or subretinal |
|
|
component is present? |
|
|
What if the sclera is thin? |
Thin sclera must not be |
The thin area should not be |
|
sutured; if the ectatic sclera |
selected as a sclerotomy site |
|
cannot be avoided, SB is |
|
|
either contraindicated or a |
|
|
scleral patch needs to be |
|
|
placed Þrst |
|
Need for detailed |
Yes |
No |
preoperative examination |
|
|
(to identify the VR |
|
|
traction and the location of |
|
|
the retinal break/s) |
|
|
Surgery doable if signiÞcant |
No |
Yes |
VH present? |
|
|
DifÞculty of intraoperatively |
Somewhat to very difÞcult |
Easy |
identifying VR traction |
|
|
Multiple breaks in multiple |
Causes decision-dilemma and |
Does not change the surgical |
quadrants |
technical difÞculties |
planning or the essence of |
|
|
surgery |
DifÞculty of intraoperatively |
May be impossible in |
Virtually always possible |
identifying retinal break |
pseudophakic eyes with |
|
|
capsular opacity, especially |
|
|
if the break is small |
|
Separation of hyaloid from |
Not needed |
A major goal of surgery but |
the retina |
|
impossible in some cases |
Draining of subretinal ßuid |
External Ð if performed at all |
Internal Ð almost always |
|
|
through the original break |
|
|
(continued) |
54.3 Treatment Principles |
|
463 |
|
|
|
Table 54.5 (continued) |
|
|
Variable |
SB |
PPV |
Complete draining of |
May be difÞcult or impossible |
Almost always possible (see the |
subretinal ßuid |
to do and risks subretinal |
text for technical details) |
|
bleeding |
|
Possibility of treating |
No |
Yes |
concurrent problems such |
|
|
as macular hole, EMP |
|
|
Cryopexy |
Even though a risk factor for |
No (laser instead; see the text |
|
PVR development, it may |
for more details) |
|
be necessary if the drainage |
|
|
was incomplete or indirect |
|
|
ophthalmoscopic laser is |
|
|
unavailable (see Chap. 29) |
|
Intravitreal gas (air) |
Risks causing secondary |
Straightforward |
tamponade |
retinal break/s |
|
Leftover ßuid under fovea |
Rather common |
No |
PVR risk |
Low (if cryopexy is not |
Low, but may be higher than |
|
applied or is done |
with SB |
|
properly) |
|
PVR prophylaxis |
Not possible |
Silicone oil use, |
|
|
chorioretinectomy, and the |
|
|
avoidance of cryopexy may |
|
|
help |
Possibility of preventing |
No |
Yes (see below) |
future EMP formation |
|
|
Side effect |
Permanent deformation of the |
Cataract in phakic eyes (will |
|
eyewall (myopia, |
eventually occur even if the |
|
astigmatism) |
patient is young) |
Intraoperative complications |
Long list (see textbooks for |
Long list (see textbooks for |
|
details) |
details) |
Postoperative complicationsa |
Long list (see textbooks for |
Long list (see textbooks for |
|
details) |
details) |
DifÞculty to do optimal |
High (ÒitÕs an artÓ) |
High (it is just as much an art as |
surgery |
|
SB is, not a Òblue-collar |
|
|
jobÓ) |
PatientsÕ preference |
No |
Yes (eye more ÒcomfortableÓ |
|
|
both during surgery and |
|
|
postoperatively) |
*Although this has been a strong trend in recent years, I have no intention here to suggest that surgeons should abandon SB and switch to PPV. Every surgeon must make his own decision based on his own preferences, rationale, and comfort zone, as well as the speciÞcs of the case. This table is provided to help with the decision-making process, not as an argument in favor of one option over another. aEMP, as one example, can occur in up to half of eyes undergoing SB and in up to a third of eyes undergoing PPV. The latter offers prevention of this complication if the ILM is removed during the original RD surgery (see Sect. 50.2.3).
464 |
54 Retinal Detachment |
|
|
Q&A
Q What is the rationale for adding a SB when PPV is performed for RD?
AIn reality, there is none. Studies consistently show that the results are not improved by adding a buckle. If PPV is performed properly (leaving no VR traction), the SB becomes superßuous. A subconscious thought process is also at play: When the surgeon performing PPV knows he will also add a buckle, he may fail to do a truly total PPV (the subpar quality of his vitrectomy will be compensated for by the buckle; see also Sect. 35.4.6.1).
Table 54.6 lists the traditional arguments favoring one procedure over the others32; pneumatic retinopexy is a procedure that has the lowest initial success rate, but, should it fail, it is ÒbenignÓ enough not to worsen the prognosis of the reoperation.
Table 54.6 Selection of the surgical procedure for RD
Variable |
SB |
Pneumatic retinopexy |
PPV |
SigniÞcant vitreous hemorrhage |
Ð |
Ð |
+ |
Mild (ÒnoÓ) VR tractiona |
+ |
+ |
+ |
SigniÞcant traction/early signs of PVR |
Ð |
Ð Ð Ð |
+ |
PVR grade C or greater |
−/+b |
− |
+++ |
Inferior break |
+ |
− |
+ |
Multiple breaks |
+c |
− |
+++ |
Posterior break |
− |
+ |
+ |
Round hole |
+++ |
+++ |
+ |
Giant tear |
−d |
− |
+ |
Dialysis |
+ |
− |
+ |
Pseudophakia |
−/+ |
− |
+++ |
High myopia |
− |
− |
+ |
RD border is right across the foveola |
− |
− |
+e |
Open-globe injury as etiology |
−/+ |
− |
+++ |
Thin sclera |
− |
+ |
+ |
aIn reality, no traction = no RD.
bOnly as an additional (to PPV) element, not as a stand-alone procedure. cIf these are fairly equidistant from the limbus.
dAdding it as element during PPV increases the risk of retinal slippage.
eThe surgeon must be careful to avoid creating a retinal fold, which would severely disturb the patientÕs vision and is difÞcult to treat once it is established.
32 All three surgical procedures are discussed in detail below.
- #28.03.202639.38 Mб0The Wills eye manual office and emergency room diagnosis and treatment of eye disease Adam T. Gerstenblith, Michael P. Rabinowitz.chm
- #
- #
- #
- #
- #
- #
- #28.03.202614.01 Кб0[Офтальмология] Jack J. Kanski Джек Дж. Кански - Клиническая офтальмология систематизированный подход [2006, PDF DjVu, RUS] [rutracker-5395873].torrent
- #
- #
- #
